MEG3 and neoplasm: Tumor growth in the GE11-VLPs-MEG3 group was significantly slower than that in the GE11-VLPs-NC and PBS groups (Figure 8A and 8B), indicating that GE11-VLPs-MEG3 could significantly inhibit tumor growth in vivo.